baber/WOPTO huggingface dataset:
Patent EP-1740115-A4 (EP)
Inventor: HOOVEN MICHAEL D
IPC: A61B18/14
Filed: 2005-04-14
Abstract: La présente invention concerne un procédé et un dispositif pour réaliser des ablations transmurales dans les tissus cardiaques, le dispositif pouvant comprendre, par exemple, au moins deux électrodes conçues pour être connectées aux pôles opposés d'un générateur FR bipolaire de façon à alimenter les électrodes en énergie pour qu'elles réalisent l'ablation des tissus cardiaques qui se trouvent entre les électrodes. Une première électrode peut être insérée dans les tissus cardiaques en un premier emplacement et une seconde électrode peut être insérée dans les tissus cardiaques en un second emplacement qui est espacé du premier. Au moins l'une des électrodes peut être conçue pour fournir une densité de courant suffisamment faible au voisinage de l'électrode, pour éviter le dessèchement substantiel des tissus lors de l'application d'énergie. De façon alternative, le dispositif peut comprendre au moins une électrode d'ablation bipolaire qui comprend un élément conducteur allongé de forme spiralée ayant un pas suffisamment petit pour fournir une aire suffisance pour éviter le dessèchement substantiel des tissus lors de l'application d'énergie par un générateur FR bipolaire.
Patent EP-1869184-A4 (EP)
Title: Identification of a beta-1,3-n-acetylgalactosaminyltransferase (cgte) from campylobacter jejuni lio87
Inventor: GILBERT MICHEL
IPC: C12P19/18
Filed: 2006-04-07
Abstract: The invention relates to β-1,3-N-acetylgalactosaminyltransferase polypeptides, nucleic acids that encode the polypeptides, and methods of using the polypeptides.
Patent EP-1905436-A4 (EP)
Inventor: LI FUCHAO
IPC: A61K31/714
Filed: 2006-07-10
Abstract: La présente invention concerne un agent synergique de temporisation pour anesthésique local. Ledit agent synergique de temporisation contient de la dopamine 0,1-100 mg, de la dexaméthasone 1-200 mg, un composé vitamine B 0,5-20 mg, de la métronidazole 10-400 mg, de la berbérine 10-1000 mg, de l’etamsylate 0,5-200 mg, de la gentamicine 40 000-800 000U et de la chymotrypsine 400-1000U. Ledit agent synergique de temporisation pour anesthésique local peut prendre effet plus rapidement et prolonger la durée de cessation de la douleur lorsqu’il est utilisé en combinaison avec un narcotique.
Patent EP-1909317-A4 (EP)
Title: Gold alloy wire for use as bonding wire exhibiting high initial bonding capability, high bonding reliability, high circularity of press bonded ball, high straight advancing property, high resin flow resistance and low specific resistance
Inventor: MAKI KAZUNARI
IPC: C22C5/02
Filed: 2006-06-08
Abstract: There are provided a gold alloy wire for a bonding wire having high initial bonding ability, high bonding reliability, high roundness of a compression ball, high straightness, high resin flowability resistance, and low specific resistance. The gold alloy wire having high initial bonding ability, high bonding reliability, high roundness of a compression ball, high straightness, high resin flowability resistance, and low specific resistance contains one or more of Pt and Pd of 500 to less than 1000 ppm in total, Ir of 1 to 100 ppm, Ca of more than 30 to 100 ppm, Eu of more than 30 to 100 ppm, Be of 0.1 to 20 ppm, if necessary, one or more of La, Ba, Sr, and Bi of 30 to 100 ppm in total, if necessary, and a balance being Au and inevitable impurities.
Patent EP-1898775-A4 (EP)
Inventor: GLOSSOP NEIL DAVID
IPC: A61B1/12
Filed: 2006-06-21
Abstract: L’invention concerne un instrument médical guidé par image qui utilise un dispositif de poursuite pour suivre l’emplacement d’au moins une portion de l’instrument sur au moins une image de l’anatomie du patient. L’instrument peut comporter une poignée ayant un élément d’actionnement, un élément de corps flexible allongé connecté à la poignée, où l’élément de corps comporte un lumen, un élément de transmission logé dans le lumen de l’élément de corps, et un appareil de traitement connecté à une extrémité de l’élément de transmission, où la commande de l’élément d’actionnement sollicite l’appareil de traitement par le biais de l’élément de transmission. L’élément de corps contient également au moins un élément capteur que le dispositif de poursuite utilise pour déterminer les informations de position concernant l’appareil de traitement servant à afficher l’emplacement de l’appareil de traitement sur l’au moins une image de l’anatomie du patient.
Patent EP-1957398-A4 (EP)
Title: Core-shell type nanoparticles and method for preparing the same
Inventor: KIM SANG-HO
IPC: B22F1/16
Filed: 2006-12-04
Abstract: Disclosed herein are core-shell type nanoparticles comprising nanoparticle cores made of a metal or semiconductor, and shells made of crystalline metal oxide formed on the surfaces of the nanoparticle cores, as well as a preparation method thereof. According to the disclosed invention, the core-shell nanoparticles, consisting of metallic or semiconductor cores and crystalline metal oxide shells, can be prepared by epitaxially growing metal oxide on the surfaces of the metallic or semiconductor nanoparticle cores. By virtue of the crystalline metal oxide shells, the core nanoparticle made of metal or semiconductor can ensure excellent chemical and mechanical stability, and the core-shell nanoparticles can show new properties resulting from the interaction between the metal cores and the metal oxide crystal shells.
Patent EP-2101898-A4 (EP)
Title: Multilayered membrane and the method of producing the membrane
Inventor: ERSKINE GILBERT
IPC: B01D69/04
Filed: 2007-06-13
Abstract: The present invention relates to the production of filter membranes (10) and in particular to multilayered filters. The invention related to a method of producing a filter membrane (10) wherein at least two layers (12, 14) are sequentially built upon a forming member (18) such that, when the forming member (18) is removed, the resultant membrane (10) includes a plurality of apertures extending therethrough, and at least some of said apertures increase in cross-sectional area from a first surface of the membrane to a second surface of the membrane. The method of production reduces the risk of permanent plugging from particulates being trapped within the membrane itself and has strong bonds between the layers which reduce the risk of separation of the layers. The present method produces an even coverage of the forming member (18) which in turn results in a layer of uniform thickness. The layer can be controlled by changing the viscosity of the mixture into which the former (18) is dipped.
Patent EP-2227132-A4 (EP)
Title: Integrated insulin delivery system with continuous glucose sensor
Inventor: DOBBLES MIKE
IPC: G16H20/17
Filed: 2007-10-09
Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
Patent EP-2105769-A4 (EP)
Title: Glass polarizer and process for producing the same
Inventor: JABRI KHALED
IPC: G02F1/1335
Filed: 2008-03-04
Abstract: A glass polarizer having an excellent transmittance and extinction ratio with respect to light in the visible light range including blue using silver halide containing glass as a starting material is provided.  A manufacturing method according to the present invention to manufacture glass polarizers is  characterized in that  borosilicate glass in which silver halide particles are dispersed and deposited by heat treatment is reduced to generate metallic silver particles from at least a portion of silver halide and then, heated for stretching to generate silver halide particles oriented and stretched in the glass.
Patent EP-2162173-A4 (EP)
Title: Prefilled retractable syringe, plunger and needle assembly therefor
Inventor: THORLEY CRAIG
IPC: A61M5/32
Filed: 2008-07-02
Abstract: A retractable syringe, plunger and releasable needle assembly including a retractable needle, a needle seal, a retaining member and an ejector member. The retaining member has a mating surface for mounting to a complementary mating surface of an interior wall of a syringe barrel. The plunger comprises a plunger outer, a plunger rod frangibly connected to a controlling member, a spring and a unitary plunger seal capable of engaging the retractable needle, wherein the plunger rod, plunger outer and the controlling member co-operate to releasably maintain the spring in an initially compressed state. After delivery of fluid contents of the syringe, the plunger forces the ejector member to release the retractable needle from the retaining member. Decompression of the spring at the end of depression of the plunger facilitates retraction of the retractable needle when engaged with the unitary plunger seal.
Patent EP-2232780-A4 (EP)
Title: Encapsulating large ethernet frames
Inventor: SULTAN ROBERT
IPC: H04L69/14
Filed: 2009-04-08
Abstract: A method comprising receiving a data frame, encapsulating the received data frame into a reflected frame message (RFM) encapsulated frame, and if the received data frame causes the RFM encapsulated frame to exceed a maximum service data unit size, either the data frame is truncated or the data frame is split into two smaller frames and those two smaller frames are encapsulated by two separate RFM frames, wherein if a truncation flag is set to be true, the data frame is truncated to be encapsulated in one RFM.
Patent EP-2496029-A4 (EP)
Title: Power saving method in wireless communication system
Inventor: LEE IL-GU
IPC: H04W52/02
Filed: 2010-10-28
Abstract: The present invention relates to a method for increasing the resource utilization rate and reducing power consumption in a high-speed wireless communication system and a control device. The method according to one embodiment of the present invention comprises a process for efficient utilization of a frequency band by including channel state information and data frame mode information in a request frame or an ack frame, before transmission in a wireless communication system. The method according to one embodiment of the present invention relates to a power saving method in a wireless communication system having at least two different transmission modes, the method comprising: a process of setting a mode in such a manner that a control frame is received in a mode with the lowest sampling speed out of three different modes available and then receiving the control frame in the set mode; and a process of setting a mode, after receiving the control frame, in such a manner that a data packet is transmitted / received in a mode with the highest transmission rate and then transmitting / receiving the data packet in the set mode.
Patent EP-2533471-A4 (EP)
Title: Method for compressing nested protocol packet header and device thereof
Inventor: ZHU LEI
IPC: H04L29/06
Filed: 2011-01-20
Abstract: Embodiments of the present invention disclose a method and apparatus for compressing a nested protocol packet header, which relate to the field of wireless communication technologies and are used to improve efficiency in compressing a nested protocol packet header in a data packet. The method for compressing a nested protocol packet header provided in the embodiments of the present invention includes: receiving a data packet sent by at least one sending end, where the data packet includes a first compression protocol packet header; taking the received data packet as a whole and nesting a second protocol packet header in it; and processing the data packet nested with the second protocol packet header, where the processing includes: coordinating part of function fields in the first compression protocol packet header and the second protocol packet header to remove a duplicate field, and compressing the second protocol packet header; and sending the processed data packet. The method and apparatus provided in the embodiments of the present invention are applicable to a data transmission process where multilayer nested compression exists.
Patent EP-2537025-A4 (EP)
Title: Protein biomarkers for obstructive airways diseases
Inventor: GIBSON PETER
IPC: G01N33/68
Filed: 2011-02-16
Abstract: Provided herein are methods for the diagnosis of obstructive airways diseases such as asthma and chronic obstructive pulmonary disease, and the discrimination between such diseases based on the expression profiles of biomarker proteins and combinations of biomarker proteins. In particular embodiments the biomarker proteins are selected from ceruloplasmin, haptoglobin, hemopexin, -2-macroglobulin, prothrombin, immunoglobulin A and complement factor H.
Patent EP-2590128-A4 (EP)
Title: Information processing device, information processing method, information processing program, and recording medium in which information processing program is recorded
Inventor: SUGIURA KENJI
IPC: G06Q30/00
Filed: 2011-06-28
Abstract: An information providing device which provides screen data including an advertisement display area, to a terminal device through a network, acquires posting information registered in a site on the network, and specifies a commercial transaction target based on the acquired posting information. The information providing device calculates the degree of attention of the commercial transaction target specified based on the acquired posting information, and determines the commercial transaction target which is an advertisement display target, based on the calculated degree of attention.
Patent EP-0079379-A4 (EP)
Title: Terminal generation of dynamically redefinable character sets.
Inventor: FLEMING JAMES RICHARD
IPC: G06T11/20
Filed: 1982-05-18
Abstract: A graphic display terminal (Fig. 1) is arranged to receive drawing instructions containing the description of a display character. The terminal, under control independent of the source, translates each received drawing instruction into a picture description bit pattern conforming to the characteristics of the terminal display device (7). The interpreted bits are then stored in a graphic repertory (10) for subsequent retrieval under control of code received from the source. In this manner dynamically redefinable character sets may be created and used without regard to a particular terminal implementation.
Patent EP-0127641-A4 (EP)
Inventor: FREEBURG THOMAS ARTHUR
IPC: H04B7/08
Filed: 1983-10-18
Abstract: Un système de communications de données (Fig. 1) couvre une zone géographique divisée en une pluralité de zones ne se chevauchant pas (Fig. 2) et comprend un contrôleur de communications générales (GCC, 104), une pluralité de modules de communications par canaux (CCM 106, 108, 110, 112) et des émetteurs associés (114, 120, 124) et des récepteurs (116, 118, 122, 126, 128), ainsi qu'une pluralité de radios portatives (130, 132, 134). Des signaux de messages portant des informations alpha-numériques sont communiqués entre le GCC (104) et les radios portatives (130, 132, 134) par une liaison radioélectrique. Chaque CCM (106, 108, 110, 112) prend une mesure de l'intensité du signal à chaque fois qu'il reçoit un signal d'un message provenant d'une radio portative (130, 132 ou 134). Le GCC (104) rassemble les mesures d'intensité des signaux à partir des récepteurs CCM (116, 118, 122, 126, 128) recevant le même signal de message et calcule une intensité ajustée du signal pour chaque zone. Le GCC (104) sélectionne ensuite la zone ayant l'intensité ajustée de signal la plus grande pour déterminer la position de la radio portative (130, 132 ou 134) qui émet le signal de message. A chaque fois que le GCC (104) envoie un signal de message à une radio portative, l'émetteur CCM (114, 120, 124) est utilisé et couvre la zone ayant l'intensité de signal ajusté la plus grande pour la dernière émission provenant de cette radio portative (130, 132, 134). Etant donné que le GCC (104) peut envoyer simultanément des signaux de messages à des radios portatives (130, 132, 134) dans d'autres zones utilisant des émetteurs CCM de non-interférence (114, 120, 124), on augmente considérablement le débit d'informations.
Patent EP-0153413-A4 (EP)
Inventor: YAMAZAKI ETUO
IPC: B23Q35/12
Filed: 1984-08-07
Abstract: Un système de changement de séquence pour un appareil de commande de profilage permet d'augmenter ou de réduire, au choix, une plage de profilage établie au préalable dans l'appareil de commande en actionnant un commutateur de commande (36) situé à l'extérieur. Dans ce but, l'appareil de commande de profilage ignore tout changement de séquence d'usinage pendant une période de temps où le commutateur de commande (36) servant à introduire un signal de changement de séquence se trouve dans un état de fonctionnement, c'est à dire, "ON". L'appareil de commande de profilage exécute un changement de séquence qui a été ignoré ou qui doit être ignoré lorsque le commutateur de commande (36) est relâché, c'est à dire lorsque le commutatur est en position "OFF".
Patent EP-0166784-A4 (EP)
Inventor: KISHI HAJIMU
IPC: B23Q15/00
Filed: 1984-12-14
Abstract: Procédé d'usinage d'une surface (AR) entourée par une courbe de contour prédéterminée (OLC) en une opération de coupe unidirectionnelle. Le procédé consiste à effectuer une coupe le long du ième cheminement de coupe (PTi); à déplacer un outil (TL) avec un mouvement de coupe le long de la courbe de contour (OLC) jusqu'à un point final d'usinage (Qi-1) du (i-1)ème passage de coupe le long duquel on a effectué l'opération de coupe préalable; à déplacer l'outil (TL) à une vitesse rapide depuis le point (Qi-1) jusqu'au point de départ d'usinage (Pi) d'un cheminement de coupe (PTi) et à positionner l'outil (TL) au point (Pi); à déplacer l'outil (TL) avec un mouvement de coupe le long de la courbe de contour (OLC) depuis le point de départ d'usinage (Pi) du cheminement de coupe (PTi) jusqu'au point de départ d'usinage (Pi+1) du cheminement d'usinage suivant (PTi+1); à déplacer l'outil (TL) avec un mouvement de coupe le long du cheminement de coupe (PTi+1), en exécutant ainsi une coupe le long du cheminement de coupe (PTi+1); à répéter ces étapes, de manière à effectuer une opération d'usinage de surface.
Patent EP-0232405-A4 (EP)
Title: Soluble phosphorylated glucan.
Inventor: DILUZIO NICHOLAS R
IPC: A61P31/00
Filed: 1986-08-13
Abstract: A new class of soluble phosphorylated glucans is described as well as the process for making the same. According to a preferred embodiment, the soluble phosphorylated glucan is derived from the yeast Saccharomyces cerevisiae. The soluble phosphorylated glucans are useful for prophylactic and therapeutic applications against neoplastic, bacteria, viral, fungal and parasitic diseases. Additionally, they may be administered as a non-toxic adjuvant, in combination with chemotherapy. The soluble phosphorylated glucans are also useful for stimulating macrophage cells, either in vivo or in vitro, to produce a cytotoxic/cyctostatic factor effective against cancer cells.
Patent EP-0250560-A4 (EP)
Title: Magnetic recorder medium having discrete magnetic storage and saturable layers and magnetic signal processing apparatus and method using the medium
IPC: G11B5/03
Filed: 1986-12-15
Abstract: Magnetic record media that have an overlying or underlying magnetically saturable high permeability keeper layer (14) in addition to a high coercivity magnetic layer (13) in which magnetic signals are stored. These media are used in magnetic signal processing devices whose transducers (15) are capable of generating a keeper layer-saturating bias flux. In signal reproduction the bias flux magnetically forms a saturation zone in the nature of virtual gap in the keeper layer that directs signal flux between the media and the transducer.
Patent EP-0258315-A4 (EP)
Title: Fluid restrictor for a valve.
Inventor: MCENEARNEY PAUL
IPC: E03B7/07
Filed: 1987-02-10
Abstract: PCT No. PCT/AU87/00035 Sec. 371 Date Dec. 7, 1987 Sec. 102(e) Date Dec. 7, 1987 PCT Filed Feb. 10, 1987 PCT Pub. No. WO87/04766 PCT Pub. Date Aug. 13, 1987.A restrictor is mounted within a passage of a control valve. The restrictor includes an annular disc having openings for the passage of fluid therethrough. The restrictor also includes a conical element coaxial with the annular disc. The restrictor limits the maximum discharge rate of fluid through the passage of the control valve.
Patent EP-0344313-A4 (EP)
Title: Probe for measuring concentration of dissolved oxygen
IPC: G01N21/64
Filed: 1988-02-19
Abstract: A probe for measuring the concentration of dissolved oxygen, which comprises a light-transmitting support having provided thereon a luminous material such as a tris(2,2'-bipyridine) ruthenium (II) complex and a carrier such as polyvinylpyrrolidone covered with an outer layer composed of a cured silicone polymer and which is used for optically measuring the concentration of gas dissolved in water or an aqueous medium such as blood. The concentration of gas dissolved in an aqueous medium is measured according to the following formula (1): Io/I = 1 + Kq.tauo[O2], wherein Io represents luminous intensity in the substantial absence of oxygen molecules, I represents luminous intensity when oxygen concentration is [O2], Kq represents a rate constant of quenching reaction, and tauo represents a luminescence life in the substantial absence of oxygen molecules. This probe shows excellent response to dissolved gas concentration, and undergoes less changes in sensitivity when used for a long time, thus being quite stable. In addition, its simple structure permits to reduce its size to such an extent that it can be provided at the tip of optical fibers to conduct the measurement in a small area such as an intravascular area.
Patent EP-0365536-A4 (EP)
Title: Biocompatible polyorganosiloxane composition for cell culture apparatus
IPC: C12N5/071
Filed: 1988-05-03
Abstract: A polyorganosiloxane composition having a biocompatible surface thereon is disclosed. The biocompatible surface results from the derivatization, or amination, of the surface intended for cell contact. More specifically, the present invention is a polyorganosiloxane composition in which the surface is either treated with a primary amine and optional peptide or the surface is co-cured with a primary amine-containing silane or siloxane. The aminated polyorganosiloxane has utility as a cell culture substrate or in a variety of artificial organ applications such as brest implants, synthetic blood vessels, joints, tendons and heart valves. A vacuum apparatus for use with specialized cell culture plates incorporating the biocompatible polyorganosiloxane composition is also disclosed.
Patent EP-0434671-A4 (EP)
Inventor: KALNINS CHARLES MICHAEL
IPC: B04C5/14
Filed: 1988-06-10
Abstract: Séparateur de liquide et procédé de séparation de liquides, tels que de l'huile et de l'eau mélangées, par utilisation d'un hydrocyclone (10). Un constituant moins dense du mélange séparé par l'hydrocyclone est passé dans un dispositif de filtration (100) pour séparation ultérieure.
Patent EP-0406426-A4 (EP)
Title: Device for automatically measuring the quantity of milk extracted by milking installation
IPC: G01F3/38
Filed: 1989-02-21
Abstract: A device for automatically measuring the quantity of milk extracted by a milking installation comprises a float-type counter (1) for the milk (3), connected to a vacuum milk line (23) and to a vacuum milk receiver (25) connected to a vacuum system (27) and to a milk pump (33) connected, in turn, to a unit (36) for setting the float-type milk counter (1) to an optimal dose of milk (3) from one cow.
Patent EP-0381721-A4 (EP)
Title: Automatic key identification system
IPC: G06V20/66
Filed: 1989-06-02
Abstract: A system for identifying and matching key blanks when duplicating an original key. A key holder is provided which positions the key horizontally along its longitudinal axis with the key's flat sides in a vertical plane. A lensing subsystem lights and forms an image of the front profile of the key. A video camera converts the light image into an electrical signal which is digitized and stored in computer memory. The computer compares the key image with stored images of known key blanks and signals the locksmith by means of an output subsystem the proper key blank to be used in duplicating the key.